![](/img/cover-not-exists.png)
Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B
Sonali M. Smith, David Grinblatt, Jeffrey L. Johnson, Donna Niedzwiecki, David Rizzieri, Nancy L. Bartlett, Bruce D. Cheson, for the Cancer, Leukemia Group BVolume:
140
Year:
2008
Language:
english
Pages:
7
DOI:
10.1111/j.1365-2141.2007.06937.x
File:
PDF, 111 KB
english, 2008